Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Regulatory News (GNS)

Share Price Information for Genus (GNS)

Share Price is delayed by 15 minutes
Get Live Data
2,020.00    -52.00 (-2.51%)
Bid:
2,008.00
Ask:
2,016.00
Spread: 8.00 (0.398%)
Market Cap: £1.34b
GNS Live PriceLast checked at - London Stock Exchange

Intraday Genus Share Chart

Board Update

26 Feb 2009 07:00

RNS Number : 8965N
Genus PLC
26 February 2009
 



For immediate release 26 February 2009

Genus plc 

("Genus" or "the Company")

Board Update

Genus, a world leading animal genetics company, today announces that John Worby has been appointed as Finance Director of the Company with immediate effect. Mr Worby replaces Martin Boden who will be leaving the Company today to pursue other opportunities. John Worby joined the Board of the Company in September 2004 when he also became Chairman of the Audit Committee. Genus intends to strengthen the non executive representation on the Board by recruiting a replacement Audit Committee Chairman and enhancing the international commercial experience of the Board, particularly in emerging markets. A further announcement on this matter will be made in due course.

For further information please contact: Genus plc Tel: 01256 345 970 John Hawkins, Chairman

Buchanan Communications Tel: 020 7466 5000 Charles Ryland Isabel Podda Jennie Spivey About Genus Genus creates advances to animal breeding through biotechnology and sells added value products for livestock farming and food producers. Its non-genetically modified organism technology is applicable across all livestock species but is only commercialised by Genus in the bovine and porcine farming sectors. Genus' worldwide sales are made in seventy countries under the trade marks "ABS" (dairy and beef cattle) and "PIC" (pigs) and comprise semen and breeding animals with superior genetics to those animals currently in production. Customers' animals produce offspring with greater production efficiency, milk and meat output and quality and use these to supply the global dairy and meat supply chain. The Group's competitive edge has been created from the ownership and control of proprietary lines of breeding animals, the biotechnology used to improve them and its global production and distribution network. Headquartered in Basingstoke, England, Genus companies operate in 30 countries on six continents, with research laboratories located in Madison, Wisconsin, USA.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOADGGZZNKMGLZM
Date   Source Headline
26th Nov 20104:27 pmRNSHolding(s) in Company
11th Nov 20103:33 pmRNSResult of AGM
11th Nov 20107:00 amRNSAGM and IMS
29th Oct 20102:30 pmRNSTotal Voting Rights
28th Oct 20107:00 amRNSStrategic Progress in India
27th Oct 20102:30 pmRNSAnnual Information Update
14th Oct 201010:00 amRNSAnnual Financial Report and AGM Meeting
30th Sep 20103:30 pmRNSTotal Voting Rights
27th Sep 20102:30 pmRNSDirector/PDMR Shareholding
22nd Sep 20103:16 pmRNSAdditional Listing
22nd Sep 20102:49 pmRNSDirector/PDMR Shareholding
15th Sep 20102:50 pmRNSDirector/PDMR Shareholding
13th Sep 201011:00 amRNSDirector/PDMR Shareholding
10th Sep 20102:00 pmRNSDirector/PDMR Shareholding
7th Sep 20107:01 amRNSBoard Change
7th Sep 20107:00 amRNSPreliminary Results
30th Jul 20102:00 pmRNSBlocklisting Interim Review
5th Jul 20107:00 amRNSPre-Close Trading Statement
17th Jun 20102:30 pmRNSHolding(s) in Company
3rd Jun 20103:30 pmRNSDirector's Shareholding
12th May 20107:00 amRNSInterim Management Statement
30th Apr 20102:00 pmRNSTotal Voting Rights
19th Apr 20102:58 pmRNSHolding(s) in Company
7th Apr 20102:00 pmRNSHolding(s) in Company
1st Apr 20102:30 pmRNSDirector/PDMR Shareholding
2nd Mar 20103:00 pmRNSDirector/PDMR Shareholding
26th Feb 20109:17 amRNSHolding(s) in Company
25th Feb 20107:00 amRNSSenior Management Appointments
25th Feb 20107:00 amRNSInterim Results
22nd Feb 20103:33 pmRNSHolding(s) in Company
29th Jan 201010:00 amRNSBlocklisting 6 Monthly Return
26th Jan 20107:00 amRNSNotice of Results
14th Jan 20105:27 pmRNSHolding(s) in Company
4th Jan 20107:00 amRNSTotal Voting Rights
30th Nov 20094:00 pmRNSTotal Voting Rights
30th Nov 20092:00 pmRNSDirector/PDMR Shareholding
17th Nov 20094:20 pmRNSHolding(s) in Company
13th Nov 20092:00 pmRNSDirector/PDMR Shareholding
12th Nov 20093:25 pmRNSResult of AGM
12th Nov 20092:15 pmRNSAGM and Interim Management Statement
30th Oct 20092:00 pmRNSTotal Voting Rights
27th Oct 20092:00 pmRNSAnnual Information Update
9th Oct 20093:58 pmRNSAnnual Financial Report and AGM
30th Sep 20092:00 pmRNSTotal Voting Rights
28th Sep 20094:10 pmRNSDirector/PDMR Shareholding
16th Sep 20092:30 pmRNSDirector/PDMR Shareholding
15th Sep 20092:32 pmRNSDirector/PDMR Shareholding
10th Sep 20094:37 pmRNSDirector/PDMR Shareholding
10th Sep 20097:00 amRNSBovine Research And Development Success
10th Sep 20097:00 amRNSPreliminary Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.